NASDAQ
FBRX

Forte Biosciences Inc

Biotechnology
Healthcare

Prices are adjusted according to historical splits.

Forte Biosciences Inc Stock Price

Vitals

Today's Low:
$0.851
Today's High:
$0.91
Open Price:
$0.851
52W Low:
$0.898
52W High:
$1.54
Prev. Close:
$0.858
Volume:
23225

Company Statistics

Market Cap.:
$21.05 million
Book Value:
1.568
Revenue TTM:
$0
Operating Margin TTM:
0%
Gross Profit TTM:
$0
Profit Margin:
0%
Return on Assets TTM:
-29.22%
Return on Equity TTM:
-49.5%

Company Profile

Forte Biosciences Inc had its IPO on 2017-04-13 under the ticker symbol FBRX.

The company operates in the Healthcare sector and Biotechnology industry. Forte Biosciences Inc has a staff strength of 7 employees.

Stock update

Shares of Forte Biosciences Inc opened at $0.85 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.85 - $0.91, and closed at $0.86.

This is a +0.47% increase from the previous day's closing price.

A total volume of 23,225 shares were traded at the close of the day’s session.

In the last one week, shares of Forte Biosciences Inc have increased by +3.86%.

Forte Biosciences Inc's Key Ratios

Forte Biosciences Inc has a market cap of $21.05 million, indicating a price to book ratio of 0.4854 and a price to sales ratio of 0.

In the last 12-months Forte Biosciences Inc’s revenue was $0 with a gross profit of $0 and an EBITDA of $-13860000. The EBITDA ratio measures Forte Biosciences Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Forte Biosciences Inc’s operating margin was 0% while its return on assets stood at -29.22% with a return of equity of -49.5%.

In Q1, Forte Biosciences Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Forte Biosciences Inc’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG

Its diluted EPS in the last 12-months stands at $-0.95 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Forte Biosciences Inc’s profitability.

Forte Biosciences Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 1.8977. Its price to sales ratio in the trailing 12-months stood at 0.

Forte Biosciences Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$36.71 million
Total Liabilities
$3.76 million
Operating Cash Flow
$0
Capital Expenditure
$0
Dividend Payout Ratio
0%

Forte Biosciences Inc ended 2024 with $36.71 million in total assets and $0 in total liabilities. Its intangible assets were valued at $36.71 million while shareholder equity stood at $32.95 million.

Forte Biosciences Inc ended 2024 with $0 in deferred long-term liabilities, $3.76 million in other current liabilities, 21000.00 in common stock, $-93797000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $35.90 million and cash and short-term investments were $35.90 million. The company’s total short-term debt was $0 while long-term debt stood at $0.

Forte Biosciences Inc’s total current assets stands at $36.27 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $1.34 million and inventory worth $0.

In 2024, Forte Biosciences Inc's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Forte Biosciences Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$0.86
52-Week High
$1.54
52-Week Low
$0.898
Analyst Target Price
$3.5

Forte Biosciences Inc stock is currently trading at $0.86 per share. It touched a 52-week high of $1.54 and a 52-week low of $1.54. Analysts tracking the stock have a 12-month average target price of $3.5.

Its 50-day moving average was $0.92 and 200-day moving average was $0.99 The short ratio stood at 1.21 indicating a short percent outstanding of 0%.

Around 1856.3% of the company’s stock are held by insiders while 3775% are held by institutions.

Frequently Asked Questions About Forte Biosciences Inc

The stock symbol (also called stock or share ticker) of Forte Biosciences Inc is FBRX

The IPO of Forte Biosciences Inc took place on 2017-04-13

Similar Industry Stocks (Biotechnology)

Last Price
Chg
Chg%
$107.73
-1.23
-1.13%
$0.41
-0.02
-3.78%
$44.2
1.82
+4.29%
$348.4
-15.35
-4.22%
$230.29
1.74
+0.76%
$2.75
-0.2
-6.78%
$32.53
0.39
+1.21%
$0.02
-0
-4.98%
Skipper Limited (SKIPPER)
$213.65
-10.85
-4.83%
$215.5
-0.5
-0.23%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Forte Biosciences, Inc. operates as a biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as graft-versus-host disease, and vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

Address

3060 Pegasus Park Drive, Dallas, TX, United States, 75247